8-KThe WireRoutine
Reg FD Disclosure
Filed Feb 11, 2026 · 4mo ago · Accession 0001193125-26-045526
Plain English
Material event — a significant development the company must disclose promptly.
Read the source below for the full document.
Filing details
- Company
- Neumora Therapeutics, Inc.
- Ticker
- NMRA
- CIK
- 1885522
- Form type
- 8-K
- Filing date
- Feb 11, 2026
- Report date
- Feb 11, 2026
- Document
- nmra-20260211.htm
- Size
- 6.4 MB